Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT04031599Completed
Randomised, open-label trial in type 1 diabetes mellitus (T1D) (2 arms), sponsored by Montreal Clinical Research Institute. Primary endpoints: Percentage of time of glucose levels spent between 3.9 and 10.0 mmol/L at 504 hours and Relative decrease in glucose levels during exercise compared to pre-breakfast levels at 4.5 hours. Started Jul 2020; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT04031599.